Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Regencell Bioscience Hldgs L (RGC)

32 + Investors. Track Smart Money conviction in RGC. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +13
Streak
6Q ▲
Buyers last Q
67%

Smart Money Signals — RGC

Based on 32 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 6 quarters in a row

last 6Q
For 6 consecutive quarters, more hedge funds added RGC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
32 hedge funds hold RGC right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +540% more funds vs a year ago

fund count last 6Q
+27 new funds entered over the past year (+540% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 67% buying

24 buying12 selling
Last quarter: 24 funds were net buyers (17 opened a brand new position + 7 added to an existing one). Only 12 were sellers (8 trimmed + 4 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+11 vs last Q)

new funds entering per quarter
Funds opening a new RGC position: 10 → 10 → 6 → 17. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

53% of holders stayed for 2+ years

53% conviction (2yr+) 9% medium 38% new
17 out of 32 hedge funds have held RGC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +32% but shares only +13% — price-driven

Value
+31%
Shares
+13%
Last quarter: the total dollar value of institutional holdings rose +32%, but actual share count only changed +13%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

3 → 10 → 10 → 6 → 17 new funds/Q
New funds entering each quarter: 10 → 10 → 6 → 17. A growing number of institutions are discovering RGC each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 59% of holders stayed 2+ years

59% veterans 3% 1-2yr 38% new
Of 34 current holders: 20 (59%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 91% AUM from top-100 funds

91% from top-100 AUM funds
14 of 32 holders are among the 100 largest funds by AUM, controlling 91% of total institutional value in RGC. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
5.9
out of 10
Moderate Exit Risk
Exit risk score 5.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — RGC

In 2026 Q1, 24 hedge funds were net buyers of RGC (17 opened a new position, 7 added to an existing one), while 12 reduced or exited (8 trimmed, 4 sold completely) — a 67% buyer ratio, indicating clear institutional accumulation. This marks 6 consecutive quarters of net institutional buying — a persistent conviction signal. 91% of total institutional value in RGC is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +13 funds (more new holders than closures). Total institutional holders: 32.

Hedge Fund Ownership: RGC

How many hedge funds hold RGC — quarterly history vs. share price
Quarterly hedge fund ownership of RGC vs. share price

Market Analysis: RGC

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: RGC

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Regencell Bioscience Hldgs L (RGC) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much RGC has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
RGC
-26.0%
XLV
+4.9%

RGC outperformed XLV by -30.9% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
RGC
-34.1%
XLV
+6.0%

Since the filing became public, RGC outperformed XLV by -40.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

3 top-rated funds 0 high-conviction
Consensus
2.6
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: RGC
32 + Investors

Track Smart Money conviction in RGC. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 32 19 68.42%
13F Shares 749K 661K 13.41%
Total Value $18M $14M 31.62%
New Positions 17 6 +11
Increased Positions 7 4 +3
Closed Positions 4 5 -1
Reduced Positions 6 7 -1
Total Calls 2 1 100.0%
Total Puts 3 3 -
PUT/CALL Ratio 1.5 3.0 Bearish

Statistics: RGC

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

32 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RGC. Verified SEC 13F-HR filings.

QUARTER:
Top 25 RGC holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Vident Advisory, LLC 0.01% 29,588 $752K
2 Squarepoint Ops LLC 0.00% 26,613 $677K
3 EverSource Wealth Advisors, LLC 0.00% 452 $18K
4 Gf Fund Management CO. LTD. 0.00% 1,064 $27K
5 Cornerstone Financial Management LLC 0.00% 15
6 Federation des caisses Desjardins du Quebec 0.00% 2,231 $57K
7 Susquehanna International Group, LLP 0.00% 38,900 $989K
8 Susquehanna International Group, LLP 0.00% 33,800 $860K
9 Bare Financial Services, Inc 0.00% 14
10 Jane Street Group, LLC 0.00% 28,000 $712K
11 UBS Group AG 0.00% 23,885 $607K
12 Citadel Advisors LLC 0.00% 21,200 $539K
13 Bell Investment Advisors, Inc 0.00% 20
14 Farther Finance Advisors, LLC 0.00% 201 $7K
15 Blue Trust, Inc. 0.00% 216 $5K
16 Amundi 0.00% 8,595 $219K
17 Legal & General Group Plc 0.00% 9,903 $252K
18 LPL Financial LLC 0.00% 8,596 $219K
19 Citadel Advisors LLC 0.00% 13,100 $333K
20 Bank of America Corp /de/ 0.00% 17,172 $437K
21 Morgan Stanley 0.00% 20,078 $511K
22 Russell Investments Group, Ltd. 0.00% 760 $19K
23 Group One Trading LLC 0.00% 354 $9K
24 GAMMA Investing LLC 0.00% 8
25 Osaic Holdings, INC. 0.00% 227 $6K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Regencell Bioscience Hldgs L (RGC)

What does the Smart Money Trend signal show for RGC?

Buying streak — 6 quarters in a row: For 6 consecutive quarters, more hedge funds added RGC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for RGC?

More buyers than sellers — 67% buying: Last quarter: 24 funds were net buyers (17 opened a brand new position + 7 added to an existing one). Only 12 were sellers (8 trimmed + 4 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for RGC holders?

Elite ownership — 91% AUM from top-100 funds: 14 of 32 holders are among the 100 largest funds by AUM, controlling 91% of total institutional value in RGC. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held RGC?

53% of holders stayed for 2+ years: 17 out of 32 hedge funds have held RGC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Regencell Bioscience Hldgs L (RGC) following the 2026 Q1 hedge fund 13F filings?

As of today, RGC has moved -34.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -40.1%. Since the quarter end (March 31, 2026), RGC has gained -26.0% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →